Patents Assigned to New Horizons Diagnostics
  • Therapeutic treatment of group A streptococcal infections
    Patent number: 6017528
    Abstract: The present invention relates to compositions containing Group C streptococcal phage associated lysin enzyme for the prophylactic and therapeutic treatment of Streptococcal infections, including the infection commonly known as strep throat. Methods for therapeutically and prophylactically treating such infections also are described.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: January 25, 2000
    Assignee: New Horizons Diagnostics
    Inventors: Vincent Fischetti, Lawrence Loomis